- Home
- ROIV vs AGI Comparison
ROIV vs AGI Comparison
Compare ROIV & AGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | AGI |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 16.3B |
| IPO Year | 2021 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ROIV | AGI |
|---|---|---|
| Price | $27.23 | $38.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $27.56 | ★ $44.33 |
| AVG Volume (30 Days) | ★ 4.5M | 3.4M |
| Earning Date | 02-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $55.02 |
| Revenue Next Year | $594.84 | $13.09 |
| P/E Ratio | ★ N/A | $34.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $23.49 |
| 52 Week High | $30.33 | $55.41 |
Technical Indicators
Market Signals| Indicator | ROIV | AGI |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 32.16 |
| Support Level | $26.94 | $37.26 |
| Resistance Level | $27.94 | $38.98 |
| Average True Range (ATR) | 0.96 | 2.24 |
| MACD | -0.38 | -1.65 |
| Stochastic Oscillator | 18.54 | 4.62 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.